The International Tennis Integrity Agency (ITIA) has today confirmed that Sydney Dorcil, a 20-year-old tennis player from the USA, has been provisionally suspended under Article 7.12.1 of the Tennis Anti-Doping Programme (TADP). The ITIA sent the player a pre-Charge Notice of an Anti-Doping Rule Violation on 10 January 2023 under Article 2.1 of the Programme (presence of a Prohibited Substance in a Player’s Sample) and/or Article 2.2 (Use of a Prohibited Substance without a valid TUE).
Dorcil, who has a highest WTA ranking of 1255, was tested whilst competing at an event in Lima, Peru in November 2022. The sample provided was split into A and B samples and the subsequent analysis of the A sample found that it contained Boldenone and its metabolites, which is a non-specified substance on the World Anti-Doping Agency prohibited list. Adverse Analytical Findings for non-Specified Substances carry a mandatory provisional suspension.
Analysis of the B sample confirmed the finding. Whilst provisionally suspended, the player is ineligible to compete in or attend any sanctioned tennis events organised by the governing bodies of the sport.
The ITIA is the delegated third party, under the World Anti-Doping Code of the International Tennis Federation, the international governing body for the sport of tennis and signatory of the Code. The ITIA is responsible for the management and administration of anti-doping across professional tennis in accordance with the TADP.
Published 20 February 2023 16:10